TB-500 (Thymosin Beta-4 fragment) Explored for inflammation response and tissue repair
Which naturally raises the question for biopharma investors and developers alike what therapeutic area could repeat this success
[1] Managing Nausea and Vomiting While Taking GLP-1s Effective management of nausea and vomiting can significantly improve treatment tolerance and adherence to GLP-1 therapy
NSF expanded beyond sanitation and is now a global public health and safety organization
The metabolic consequences of obesityparticularly insulin resistance, hypothalamic dysfunction, and impaired mitochondrial metabolismare increasingly recognized as playing central roles in migraine pathophysiology
PubMed Sattar, N., McGuire, D.K., Pavo, I., Weerakkody, G.J., Nishiyama, H., Wiese, R.J., & Zoungas, S